Two-year outcome of Galantamine treatment in Alzheimer’s disease in a routine clinical setting.
Åsa Wallin, Carina Wattmo, Annacarin Björkman, Sture Eriksson, Niels Andreasen, Lennart Minthon
Research output: Contribution to conference › Poster
235
Downloads
(Pure)